Walgreens Boots Alliance (NASDAQ:WBA) issued an update on its FY 2019 earnings guidance on Thursday morning. The company provided EPS guidance of $6.40-6.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.46.
Shares of WBA stock opened at $73.50 on Friday. Walgreens Boots Alliance has a one year low of $59.07 and a one year high of $80.68. The company has a quick ratio of 0.47, a current ratio of 0.93 and a debt-to-equity ratio of 0.44. The company has a market cap of $72.35 billion, a P/E ratio of 14.41, a P/E/G ratio of 1.11 and a beta of 1.04.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, topping the consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a net margin of 3.36% and a return on equity of 21.22%. The firm had revenue of $33.44 billion during the quarter, compared to analyst estimates of $33.64 billion. Research analysts anticipate that Walgreens Boots Alliance will post 5.98 EPS for the current year.
WBA has been the subject of several research analyst reports. TheStreet raised shares of Walgreens Boots Alliance from a c+ rating to a b rating in a research report on Wednesday, September 12th. Loop Capital upped their price target on shares of Walgreens Boots Alliance to $80.00 and gave the stock a buy rating in a research report on Friday, June 29th. Zacks Investment Research raised shares of Walgreens Boots Alliance from a hold rating to a buy rating and set a $72.00 price target for the company in a research report on Tuesday, June 19th. BidaskClub raised shares of Walgreens Boots Alliance from a hold rating to a buy rating in a research report on Wednesday, July 18th. Finally, Pivotal Research dropped their price target on shares of Walgreens Boots Alliance from $70.00 to $60.00 and set a hold rating for the company in a research report on Monday, July 2nd. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of Hold and a consensus target price of $76.94.
In other Walgreens Boots Alliance news, insider Stefano Pessina acquired 1,697,438 shares of the company’s stock in a transaction dated Monday, July 16th. The stock was bought at an average price of $63.92 per share, with a total value of $108,500,236.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Ornella Barra acquired 1,700,000 shares of the company’s stock in a transaction dated Monday, July 16th. The stock was acquired at an average cost of $65.15 per share, with a total value of $110,755,000.00. The disclosure for this purchase can be found here. 14.80% of the stock is owned by corporate insiders.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Further Reading: What is a Stop Order?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.